Experience

KBP Biosciences

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Director Of Business Development

  • Oct 2020 - Present

  KBP Biosciences (https://www.kbpbiosciences.com/) is a global, clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved patient populations in organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company to efficiently bring new therapies from bench to patients around the world. Our lead product… Show more KBP Biosciences (https://www.kbpbiosciences.com/) is a global, clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved patient populations in organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company to efficiently bring new therapies from bench to patients around the world. Our lead product candidate, Ocedurenone (https://www.kbpbio.com/index.php?c=show&id=26), is a third-generation non-steroidal mineralocorticoid receptor antagonist (MRA) with a potentially best-in-class safety and efficacy profile. It is in Phase 3 clinical development for the treatment of uncontrolled hypertension and cardiorenal disease in stage 3b/4 Chronic Kidney Disease (CKD) patients who have high risk of hyperkalemia. KBP is also developing Zifanocycline (https://www.kbpbio.com/index.php?c=show&id=25), a Phase 2 ready third-generation aminomethylcycline for the treatment of multiple strains of drug-resistant infections with high activity against certain key pathogens. KBP has built a proprietary R&D platform aimed at the discovery and development of global first-in-class compounds. The platform includes a compound library which is the basis of new compound discovery, a bacterium library aimed at multi-drug resistant bacteria, and an in vivo pharmacology platform for screening and testing new compounds. KBP Biosciences is actively seeking to identify additional promising therapeutic opportunities and further develop its product portfolio. Show less KBP Biosciences (https://www.kbpbiosciences.com/) is a global, clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved patient populations in organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company to efficiently bring new therapies from bench to patients around the world. Our lead product… Show more KBP Biosciences (https://www.kbpbiosciences.com/) is a global, clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved patient populations in organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company to efficiently bring new therapies from bench to patients around the world. Our lead product candidate, Ocedurenone (https://www.kbpbio.com/index.php?c=show&id=26), is a third-generation non-steroidal mineralocorticoid receptor antagonist (MRA) with a potentially best-in-class safety and efficacy profile. It is in Phase 3 clinical development for the treatment of uncontrolled hypertension and cardiorenal disease in stage 3b/4 Chronic Kidney Disease (CKD) patients who have high risk of hyperkalemia. KBP is also developing Zifanocycline (https://www.kbpbio.com/index.php?c=show&id=25), a Phase 2 ready third-generation aminomethylcycline for the treatment of multiple strains of drug-resistant infections with high activity against certain key pathogens. KBP has built a proprietary R&D platform aimed at the discovery and development of global first-in-class compounds. The platform includes a compound library which is the basis of new compound discovery, a bacterium library aimed at multi-drug resistant bacteria, and an in vivo pharmacology platform for screening and testing new compounds. KBP Biosciences is actively seeking to identify additional promising therapeutic opportunities and further develop its product portfolio. Show less



JDRF International

• United States
• Fundraising
• 500 - 600 Employee

• Director, Research Partnerships

  • Sep 2018 - Mar 2020

  Driving the successful execution of JDRF’s research strategy by identifying, evaluating, and implementing external project and partnership opportunities in alignment with JDRF’s objectives. - Acting as an internal “entrepreneur” to: (i) Identify and evaluate internal and external opportunities (ii) Define and grow areas of strategic focus within JDRF’s priorities (iii) Find creative ways to advance programs through partnering (iv) Provide leadership to partnered… Show more Driving the successful execution of JDRF’s research strategy by identifying, evaluating, and implementing external project and partnership opportunities in alignment with JDRF’s objectives. - Acting as an internal “entrepreneur” to: (i) Identify and evaluate internal and external opportunities (ii) Define and grow areas of strategic focus within JDRF’s priorities (iii) Find creative ways to advance programs through partnering (iv) Provide leadership to partnered projects Show less Driving the successful execution of JDRF’s research strategy by identifying, evaluating, and implementing external project and partnership opportunities in alignment with JDRF’s objectives. - Acting as an internal “entrepreneur” to: (i) Identify and evaluate internal and external opportunities (ii) Define and grow areas of strategic focus within JDRF’s priorities (iii) Find creative ways to advance programs through partnering (iv) Provide leadership to partnered… Show more Driving the successful execution of JDRF’s research strategy by identifying, evaluating, and implementing external project and partnership opportunities in alignment with JDRF’s objectives. - Acting as an internal “entrepreneur” to: (i) Identify and evaluate internal and external opportunities (ii) Define and grow areas of strategic focus within JDRF’s priorities (iii) Find creative ways to advance programs through partnering (iv) Provide leadership to partnered projects Show less



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director, Open Innovation

  • Jun 2010 - Sep 2015

  Core member of the Consumer Healthcare R&D Open Innovation team, and category Portfolio Management Boards. Developed, led, and executed category-specific external innovation strategies. Maintained strong relationships with a network of key vendors, collaborators, and potential partners. Primary point of contact with external innovation partners, leading due diligence of technologies.

• Associate Director, Open Innovation Team

  • Nov 2007 - Oct 2011

  Used robust external search and evaluation approaches to identify breakthrough technologies. Developed and led internal program of GSK staff in various functions and locations, tasked with identifying technologies in their local regions (Global Technology Scout program). Increased awareness of GSK Open Innovation, and it’s status as partner-of-choice by presenting at industry, academic, and Open Innovation conferences.



Redpoint Bio Corp

• Ewing New Jersey, USA

• Director, Technology Assessment

  • May 1996 - Nov 2007

  Reporting directly to the CEO, developed new business relationships with external partners, and identified and negotiated in-licensing of technology essential to company’s growth. Alliance manager and member of steering committee for all external agreements. Scientific representative in negotiations with business and academic partners, and venture capitalists. Planned, budgeted, and wrote collaboration proposals. Led regulatory affairs program. Reporting directly to the CEO, developed new business relationships with external partners, and identified and negotiated in-licensing of technology essential to company’s growth. Alliance manager and member of steering committee for all external agreements. Scientific representative in negotiations with business and academic partners, and venture capitalists. Planned, budgeted, and wrote collaboration proposals. Led regulatory affairs program.